Current Treatment of Papillary Thyroid Microcarcinoma

Advances in Surgery

Volumn 46, Issue 1, 2012, Pages 191-203

  Yu, Xiao Min ^a   Lloyd, Ricardo ^b   Chen, Herbert ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

ATA guidelines; Papillary thyroid microcarcinoma; Prognostic factors; Thyroid cancer; Treatment

Indexed keywords

CANCER INVASION; HUMAN; LYMPH NODE METASTASIS; NEEDLE BIOPSY; PATHOLOGY; PLOIDY; PROGNOSIS; REVIEW; THYROID TUMOR;

BIOPSY, FINE-NEEDLE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PLOIDIES; PROGNOSIS; THYROID NEOPLASMS;

EID: 84863465935     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2012.03.002     Document Type: Review

References (44)

1. Cramer J.D., Fu P., Harth K.C., et al. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry. Surgery 2010, 148(6):1147-1152. [discussion: 1152-3].
2. Hughes D.T., Haymart M.R., Miller B.S., et al. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 2011, 21(3):231-236.
3. Haymart M.R., Cayo M., Chen H. Papillary thyroid microcarcinomas: big decisions for a small tumor. Ann Surg Oncol 2009, 16(11):3132-3139.
4. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006, 16(2):109-142.
5. Pacini F., Schlumberger M., Dralle H., et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006, 154(6):787-803.
6. Mazeh H., Chen H. Advances in surgical therapy for thyroid cancer. Nat Rev Endocrinol 2011, 7(10):581-588.
7. Ito Y., Miyauchi A. A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab 2007, 3(3):240-248.
8. Witterick I.J., Abel S.M., Noyek A.M., et al. Nonpalpable occult and metastatic papillary thyroid carcinoma. Laryngoscope 1993, 103(2):149-155.
9. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 1994, 69(1):44-49.
10. Cooper D.S., Doherty G.M., Haugen B.R., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19(11):1167-1214.
11. Mazzaglia P.J. Surgeon-performed ultrasound in patients referred for thyroid disease improves patient care by minimizing performance of unnecessary procedures and optimizing surgical treatment. World J Surg 2010, 34(6):1164-1170.
12. Goldfarb M., Gondek S., Solorzano C., et al. Surgeon-performed ultrasound can predict benignity in thyroid nodules. Surgery 2011, 150(3):436-441.
13. Milas M., Stephen A., Berber E., et al. Ultrasonography for the endocrine surgeon: a valuable clinical tool that enhances diagnostic and therapeutic outcomes. Surgery 2005, 138(6):1193-1200. [discussion: 1200-1].
14. Sherman S.I. Thyroid carcinoma. Lancet 2003, 361(9356):501-511.
15. Yu X.M., Wan Y., Sippel R.S., et al. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 2011, 254(4):653-660.
16. Hay I.D., Grant C.S., Taylor W.F., et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987, 102(6):1088-1095.
17. Hay I.D., Bergstralh E.J., Goellner J.R., et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993, 114(6):1050-1057. [discussion: 1057-8].
18. Cady B., Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988, 104(6):947-953.
19. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual 2002, Springer-Verlag, New York. 6th edition.
20. Bernet V. Approach to the patient with incidental papillary microcarcinoma. J Clin Endocrinol Metab 2010, 95(8):3586-3592.
21. Kasai N., Sakamoto A. New subgrouping of small thyroid carcinomas. Cancer 1987, 60(8):1767-1770.
22. Giordano D., Gradoni P., Oretti G., et al. Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol 2010, 35(2):118-124.
23. Pellegriti G., Scollo C., Lumera G., et al. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004, 89(8):3713-3720.
24. Hay I.D., Hutchinson M.E., Gonzalez-Losada T., et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 2008, 144(6):980-987. [discussion: 987-8].
25. Piersanti M., Ezzat S., Asa S.L. Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol 2003, 14(3):183-191.
26. Baudin E., Travagli J.P., Ropers J., et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 1998, 83(3):553-559.
27. Chow S.M., Law S.C., Chan J.K., et al. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer 2003, 98(1):31-40.
28. Wada N., Duh Q.Y., Sugino K., et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003, 237(3):399-407.
29. Mercante G., Frasoldati A., Pedroni C., et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 2009, 19(7):707-716.
30. Besic N., Zgajnar J., Hocevar M., et al. Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience. Ann Surg Oncol 2009, 16(4):920-928.
31. Lombardi C.P., Bellantone R., De Crea C., et al. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg 2010, 34(6):1214-1221.
32. Sellers M., Beenken S., Blankenship A., et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 1992, 164(6):578-581.
33. Mazzaferri E.L., Young R.L. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981, 70(3):511-518.
34. Pasieka J.L., Zedenius J., Auer G., et al. Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 1992, 112(6):1154-1159. [discussion: 1159-60].
35. Xing M. BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management. Ann Surg Oncol 2009, 16(4):801-803.
36. Melck A.L., Yip L., Carty S.E. The utility of BRAF testing in the management of papillary thyroid cancer. Oncologist 2010, 15(12):1285-1293.
37. Ito Y., Uruno T., Nakano K., et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003, 13(4):381-387.
38. Xiao X., Ning L., Chen H. Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors. Mol Cancer Ther 2009, 8(2):350-356.
39. Ross D.S., Litofsky D., Ain K.B., et al. Recurrence after treatment of micropapillary thyroid cancer. Thyroid 2009, 19(10):1043-1048.
40. Jukkola A., Bloigu R., Ebeling T., et al. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004, 11(3):571-579.
41. Sugitani I., Kasai N., Fujimoto Y., et al. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004, 135(2):139-148.
42. Ito Y., Tomoda C., Uruno T., et al. Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg 2004, 28(5):498-501.
43. So Y.K., Son Y.I., Hong S.D., et al. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery 2010, 148(3):526-531.
44. Pearce E.N., Braverman L.E. Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab 2004, 89(8):3710-3712.